Buscar resultados de ensayos clínicos
Purpura, Thrombotic Thrombocytopenic - 25 Studies Found
Estado | Estudiar |
Withdrawn |
Nombre del estudio: Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura Condición: Purpura, Thrombotic Thrombocytopenic Fecha: 2012-12-12 Intervenciones:
|
Terminated |
Nombre del estudio: IdeS in Asymptomatic Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients Condición: Purpura, Thrombotic Thrombocytopenic Fecha: 2016-07-27 Intervenciones: Biological: HMed-IdeS One dose of 0.25 mg/kg BW HMed-IdeS on study day 0. Following and evaluation of ef |
Recruiting |
Nombre del estudio: Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP) Condición: Thrombotic Thrombocytopenic Purpura Fecha: 2009-08-04 Intervenciones: Drug: Danazol Danazol 600 mg PO will be initiated with plasma exchange and corticosteroids at the time o |
Completed |
Nombre del estudio: ADAMTS13 in Thrombotic Thrombocytopenic Purpura Condición: Thrombotic Thrombocytopenic Purpura Fecha: 2007-01-24 |
Withdrawn |
Nombre del estudio: Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura Condición: Thrombotic Thrombocytopenic Purpura Fecha: 2005-11-07 Intervenciones: Drug: Rituximab Rituximab will be administered immediately after pheresis to minimize the amount of Ritu |
Completed |
Nombre del estudio: Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura Condición: Thrombotic Thrombocytopenic Purpura Fecha: 2009-05-22 Intervenciones: Drug: rituximab Patients will be treated according to the recommendations of the Reference Centre for th |
Active, not recruiting |
Nombre del estudio: Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP) Condición: Thrombotic Thrombocytopenic Purpura Fecha: 2008-07-09 Intervenciones:
|
Completed |
Nombre del estudio: Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP) Condición: Thrombotic Thrombocytopenic Purpura Fecha: 2010-06-25 Intervenciones:
|
Recruiting |
Nombre del estudio: Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura Condición: Acquired Thrombotic Thrombocytopenic Purpura Fecha: 2015-09-14 Intervenciones:
|
Recruiting |
Nombre del estudio: The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP) Condición: Thrombotic Thrombocytopenic Purpura (TTP) Fecha: 2009-07-09 Intervenciones: Drug: Rituximab Concentrate for solution for infusion, Intravenous use, 375mg/m2, Maximum 8 weekly infus |